Skip to Main Content
Mental Health & Behavioral Research, Phase Pilot

Mavoglurant in Alcohol Drinking

What is the purpose of this trial?

The purpose of this alcohol-interaction pilot study is to provide information on the effect of mavoglurant on the pharmacokinetics of alcohol and on alcohol responses, including stimulation, sedation, intoxication, body sway and physiological responses. The investigators propose to test the effects of 200 mg mavoglurant versus placebo on alcohol related responses. This is a between subjects double blind randomized design in which the investigators plan to run 14 subjects to obtain 10 completers.

  • Trial with
    National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • Ages
    21 years - 50 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Nicholas Franco

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    02/02/2024
  • Study HIC
    #2000021703